Biogen reported $23.9M in Interest Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Income Change
ALKERMES ALKS:US USD 2.24M 1.34M
Biogen BIIB:US USD 23.9M 11.3M
BioMarin Pharmaceutical BMRN:US USD 5M 2.49M
Bluebird Bio BLUE:US USD 383K 209K
Eli Lilly LLY:US USD 20.1M 9.9M
Esperion Therapeutics ESPR:US USD 800K 400K
Intra Cellular Therapies ITCI:US USD 2.12M 802K
Marinus Pharmaceuticals MRNS:US USD 514K 430K
Moderna Inc MRNA:US USD 58M 18M
Pfizer PFE:US USD 70M 40M
Puma Biotechnology PBYI:US USD 216K 151K
Sangamo BioSciences SGMO:US USD 1.77M 874K
Sarepta Therapeutics SRPT:US USD 4.78M 2.37M
Ultragenyx Pharmaceutical RARE:US USD 3.48M 2.58M
United Therapeutics UTHR:US USD 13.3M 6.5M
Vertex Pharmaceuticals VRTX:US USD 46.2M 35.4M